Skip to main content
logo
Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
7.91
-0.02 (-0.25%)
At close: Sep 29, 2026, 4:00 PM EDT
7.98
+0.07 (0.93%)
After-hours: Sep 29, 2026, 7:54 PM EDT

Alignment Healthcare Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Premiums & Annuity Revenue
4,5414,2203,9123,6003,3012,9682,6722,4392,2051,9881,8011,7021,6121,5211,4321,3701,3031,2451,1671,111
Other Revenue
36.6736.743737.4435.3733.4731.6328.5527.0925.422.718.0311.936.722.611.10.920.840.691.21
Total Revenue
4,5774,2573,9493,6373,3363,0022,7042,4682,2322,0131,8241,7201,6241,5281,4341,3711,3041,2461,1681,112
Revenue Growth (YoY)
37.21%41.81%46.06%47.39%49.46%49.12%48.25%43.47%37.46%31.76%27.16%25.49%24.54%22.59%22.81%23.27%22.27%24.41%21.74%-
Policy Benefits
4,0033,7303,4603,1852,9302,6542,4062,2101,9941,8001,6231,5311,4461,3421,2501,1831,1251,0921,039994.48
Depreciation & Amortization
31.5330.6829.828.127.7727.2626.2725.9123.7722.4721.4120.319.2618.2417.2716.6716.316.0315.8115.8
Selling, General & Administrative
487.01459.8442.49418.84399.78383.45369.81353.76344.48327.22307.43304.97300.29291.76295.65290.5290.89300.37290.99264.03
Total Operating Expenses
4,5214,2203,9323,6323,3583,0642,8022,5892,3622,1491,9511,8561,7651,6521,5631,4911,4321,4081,3461,274
Operating Income
55.8836.5316.275.46-21.84-62.57-98.59-121.7-130.44-136.11-127.82-136.06-141.66-124.65-128.64-120-128.04-161.88-178.07-162.4
Interest Expense
-16.24-15.91-15.8-17.34-20.33-22.07-23.55-23.54-22.07-21.64-21.23-20.54-19.68-18.91-18.29-17.95-17.76-17.6-17.44-17.3
Other Non Operating Income (Expenses)
-0.010.02-0.14-0.11-0.030.060.360.480.530.561.111.10.51-0.08-0.17-0.250.250.230.2
EBT Excluding Unusual Items
39.6420.620.48-12.02-42.28-84.66-122.08-144.88-152.02-157.23-148.48-155.49-160.25-143.05-147-138.12-146.05-179.23-195.29-179.5
Merger & Restructuring Charges
----2.36-2.36-2.36-2.36-------------
Impairment of Goodwill
0.030.03-0.6-0.63-0.63-0.63--------------
Gain (Loss) on Sale of Assets
00.070.070.220.220.150.01-0.14-0.140.150.290.190.19-0.1-0.1-----0.02
Asset Writedown
----0.6-0.6-0.6-0.6-----0.51-0.51-0.51------
Legal Settlements
-0.91-0.91-0.910.630.720.32-0.77-0.72-0.32--1.95--------
Other Unusual Items
----3.02-3.02-3.02-3.02------2.2-2.2-2.2-2.2----
Pretax Income
38.7719.82-0.96-17.78-47.95-90.81-128.05-144.25-152.89-157.4-148.2-157.76-162.77-145.85-149.3-140.31-146.05-179.23-195.29-179.52
Income Tax Expense
-1.930.020.023.253.240.040.02-0.01-0-0.02-0.020.170.340.340.340.17----
Earnings From Continuing Ops.
40.719.79-0.98-21.04-51.19-90.85-128.07-144.24-152.89-157.38-148.17-157.94-163.11-146.19-149.64-140.48-146.05-179.23-195.29-179.52
Minority Interest in Earnings
-0.010.250.230.240.220.040.090.10.120.160.230.20.180.09-----
Net Income
40.719.81-0.72-20.81-50.95-90.63-128.04-144.15-152.79-157.25-148.02-157.71-162.91-146.01-149.55-140.48-146.05-179.23-195.29-179.52
Net Income to Common
40.719.81-0.72-20.81-50.95-90.63-128.04-144.15-152.79-157.25-148.02-157.71-162.91-146.01-149.55-140.48-146.05-179.23-195.29-179.52
Net Income Growth (YoY)
--------------------
Shares Outstanding (Basic)
203201198196194192191190189188186185183182181180179178172168
Shares Outstanding (Diluted)
204203198196194192191190189188186185183182181180179178172168
Shares Change (YoY)
5.47%5.70%3.78%3.06%2.59%2.27%2.46%2.79%2.97%2.97%2.76%2.54%2.41%2.36%5.38%7.31%10.93%14.48%13.03%-
EPS (Basic)
0.200.10-0.00-0.11-0.26-0.47-0.67-0.76-0.81-0.84-0.79-0.85-0.89-0.80-0.83-0.78-0.82-1.01-1.14-1.07
EPS (Diluted)
0.200.10-0.00-0.11-0.27-0.48-0.67-0.76-0.81-0.84-0.79-0.85-0.89-0.80-0.83-0.78-0.82-1.01-1.14-1.07
EPS Growth (YoY)
--------------------

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
177.51226.1113.15150.5628.4119.08-6.65-186.72-207.19-190.37-95.18-52.8449.2925.18-69.253.43-38.17-72.54-98.54-80.33
Free Cash Flow Per Share
0.871.110.570.770.150.10-0.04-0.98-1.10-1.01-0.51-0.290.270.14-0.380.30-0.21-0.41-0.57-0.48
Operating Margin
1.22%0.86%0.41%0.15%-0.66%-2.08%-3.65%-4.93%-5.84%-6.76%-7.01%-7.91%-8.72%-8.16%-8.97%-8.76%-9.82%-12.99%-15.25%-14.61%
Profit Margin
0.89%0.46%-0.02%-0.57%-1.53%-3.02%-4.74%-5.84%-6.84%-7.81%-8.12%-9.17%-10.03%-9.56%-10.43%-10.25%-11.20%-14.38%-16.72%-16.14%
Free Cash Flow Margin
3.88%5.31%2.86%4.14%0.85%0.64%-0.25%-7.57%-9.28%-9.46%-5.22%-3.07%3.04%1.65%-4.83%3.90%-2.93%-5.82%-8.44%-7.22%
EBITDA
87.4267.2446.1133.636.04-35.18-72.18-95.58-106.45-113.4-106.15-115.5-122.15-106.18-111.15-103.12-111.54-145.65-162.04-146.36
EBITDA Margin
1.91%1.58%1.17%0.92%0.18%-1.17%-2.67%-3.87%-4.77%-5.63%-5.82%-6.71%-7.52%-6.95%-7.75%-7.52%-8.55%-11.69%-13.88%-13.16%
D&A For EBITDA
31.5430.7229.8528.1827.8827.3826.4226.1223.9922.7221.6720.5619.5118.4817.4916.8816.516.2416.0316.04
EBIT
55.8836.5316.275.46-21.84-62.57-98.59-121.7-130.44-136.11-127.82-136.06-141.66-124.65-128.64-120-128.04-161.88-178.07-162.4
EBIT Margin
1.22%0.86%0.41%0.15%-0.65%-2.08%-3.65%-4.93%-5.84%-6.76%-7.01%-7.91%-8.72%-8.16%-8.97%-8.76%-9.82%-12.99%-15.25%-14.61%
Effective Tax Rate
-0.12%------------------
Revenue as Reported
4,5774,2573,9493,6373,3363,0022,7042,4682,2322,0131,8241,7201,6241,5281,4341,3711,3041,2461,1681,112
SEC Filings: 10-K · 10-Q